TABLE 2.
Demographic and Clinical Characteristics
| N = 15 | |
|---|---|
| Age, yr | |
| M (SD) | 44.6 (14.9) |
| % Female | 53 |
| % White | 87 |
| % Right hand dominant | 100 |
| Education, yr | |
| M (SD) | 16.0 (2.7) |
| Seizure history, % yes | 80 |
| AED at preop scan, % yes | 87 |
| AED at postop scan, % yes | 93 |
| Steroid at preop scan, % yes | 53 |
| Steroid at postop scan, % yes | 53 |
| Preop scan to resection, d | |
| M (SD) | 2.3 (2.2) |
| Resection to postop scan, d | |
| M (SD) | 17.1 (6.4) |
| Preop NCF testing to resection, d | |
| M (SD) | 2.8 (2.1) |
| Resection to postop NCF testing, d | |
| M (SD) | 33.2 (27.1) |
| Hemisphere lesion, % | |
| Left | 100 |
| Lesion location, % | |
| Frontal | 47 |
| Temporal | 40 |
| Parietal | 13 |
| Lesion volume | |
| Preop FLAIR, cm3 | |
| M (SD) | 61.4 (37.1) |
| Postop FLAIR, cm3 | |
| M (SD) | 10.7 (13.6) |
| Residual FLAIR, % | |
| M (SD) | 15.9 (15.4) |
| Extent of resection, % | |
| Gross total | 47 |
| Near total | 20 |
| Subtotal | 33 |
| Awake craniotomy, % yes | 100 |
| Prior intervention, % | |
| None | 33 |
| Biopsy | 67 |
| Tumor grade, % | |
| II | 53 |
| III | 7 |
| IV | 40 |
| Histology, % | |
| Glioblastoma | 40 |
| Astrocytoma | 47 |
| Oligodendroglioma | 13 |
AED, antiepileptic drug.